Fibrin clot strength is associated with increased risk of major adverse cardiac events after TAVR Cardiovascular Risk and DiseasesTherapy and Intervention Share: Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me Forgot password? Click here
Do you want to read an article? Please log in or register. E mail Password Login Register for Free Remember me